A Study to Assess the Transfer of Fospropofol and Its Active Metabolite, Propofol, to Breast Milk Following Administration of LUSEDRA to Lactating Women Undergoing a Needed Procedure

Completed · Phase 1

Conditions studied: Lactating Women

In brief

The purpose of this study is to assess the transfer of fospropofol and its active metabolite, propofol, to breast milk following administration of LUSEDRA® to lactating women undergoing a needed procedure.

Key facts

Study ID

NCT01309984

Run by

Eisai Inc.

People needed

10

Starts

2010-11-01

Expected to finish

2012-10-01

Last updated by the study team

2015-11-03

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: not accepted.

Where it is running

• NorthShore University HealthSystem — Evanston, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.